<!DOCTYPE html>
<!--[if IE 7]>    <html class="ie ie7 lt-ie9 lt-ie8" lang="en"> <![endif]-->
<!--[if IE 8]>    <html class="ie ie8 lt-ie9" lang="en"> <![endif]-->
<!--[if gt IE 8]><!--> <html lang="en" class="no-js"> <!--<![endif]-->
<head>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"bam.nr-data.net","licenseKey":"5b06465c9f","applicationID":"367227","transactionName":"el9cTBRXCl8EFk5wX1dEV1YSewldFRYOX1xcQhFLDlcRHlFJUAM=","queueTime":3,"applicationTime":131,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-411.min.js"}</script>
<script type="text/javascript">(window.NREUM||(NREUM={})).loader_config={xpid:"VwcEVlFACwUHVlNV"};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o?o:e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e){function n(t,e,n){n||(n={});for(var r=o[t],a=r&&r.length||0,s=n[i]||(n[i]={}),u=0;a>u;u++)r[u].apply(s,e);return s}function r(t,e){var n=o[t]||(o[t]=[]);n.push(e)}var o={},i="nr@context";e.exports={on:r,emit:n}},{}],2:[function(t){function e(t,e,n,i,s){return u?u-=1:r("err",[s||new UncaughtException(t,e,n)]),"function"==typeof a?a.apply(this,o(arguments)):!1}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function n(t){r("err",[t,(new Date).getTime()])}var r=t("handle"),o=t(6),i=t(5),a=window.onerror,s=!1,u=0;t("loader").features.push("err"),window.onerror=e,NREUM.noticeError=n;try{throw new Error}catch(d){"stack"in d&&(t(1),t(2),"addEventListener"in window&&t(3),window.XMLHttpRequest&&XMLHttpRequest.prototype&&XMLHttpRequest.prototype.addEventListener&&t(4),s=!0)}i.on("fn-start",function(){s&&(u+=1)}),i.on("fn-err",function(t,e,r){s&&(this.thrown=!0,n(r))}),i.on("fn-end",function(){s&&!this.thrown&&u>0&&(u-=1)}),i.on("internal-error",function(t){r("ierr",[t,(new Date).getTime(),!0])})},{1:5,2:4,3:3,4:6,5:1,6:14,handle:"D5DuLP",loader:"G9z0Bl"}],3:[function(t){function e(t){r.inPlace(t,["addEventListener","removeEventListener"],"-",n)}function n(t){return t[1]}var r=t(1),o=(t(3),t(2));if(e(window),"getPrototypeOf"in Object){for(var i=document;i&&!i.hasOwnProperty("addEventListener");)i=Object.getPrototypeOf(i);i&&e(i);for(var a=XMLHttpRequest.prototype;a&&!a.hasOwnProperty("addEventListener");)a=Object.getPrototypeOf(a);a&&e(a)}else XMLHttpRequest.prototype.hasOwnProperty("addEventListener")&&e(XMLHttpRequest.prototype);o.on("addEventListener-start",function(t){if(t[1]){var e=t[1];"function"==typeof e?this.wrapped=e["nr@wrapped"]?t[1]=e["nr@wrapped"]:e["nr@wrapped"]=t[1]=r(e,"fn-"):"function"==typeof e.handleEvent&&r.inPlace(e,["handleEvent"],"fn-")}}),o.on("removeEventListener-start",function(t){var e=this.wrapped;e&&(t[1]=e)})},{1:15,2:1,3:14}],4:[function(t){var e=(t(3),t(1)),n=t(2);e.inPlace(window,["requestAnimationFrame","mozRequestAnimationFrame","webkitRequestAnimationFrame","msRequestAnimationFrame"],"raf-"),n.on("raf-start",function(t){t[0]=e(t[0],"fn-")})},{1:15,2:1,3:14}],5:[function(t){function e(t){var e=t[0];"string"==typeof e&&(e=new Function(e)),t[0]=n(e,"fn-")}var n=(t(3),t(1)),r=t(2);n.inPlace(window,["setTimeout","setInterval","setImmediate"],"setTimer-"),r.on("setTimer-start",e)},{1:15,2:1,3:14}],6:[function(t){function e(){o.inPlace(this,s,"fn-")}function n(t,e){o.inPlace(e,["onreadystatechange"],"fn-")}function r(t,e){return e}var o=t(1),i=t(2),a=window.XMLHttpRequest,s=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"];window.XMLHttpRequest=function(t){var n=new a(t);try{i.emit("new-xhr",[],n),o.inPlace(n,["addEventListener","removeEventListener"],"-",function(t,e){return e}),n.addEventListener("readystatechange",e,!1)}catch(r){try{i.emit("internal-error",r)}catch(s){}}return n},window.XMLHttpRequest.prototype=a.prototype,o.inPlace(XMLHttpRequest.prototype,["open","send"],"-xhr-",r),i.on("send-xhr-start",n),i.on("open-xhr-start",n)},{1:15,2:1}],7:[function(t){function e(){function e(t){if("string"==typeof t&&t.length)return t.length;if("object"!=typeof t)return void 0;if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if("undefined"!=typeof FormData&&t instanceof FormData)return void 0;try{return JSON.stringify(t).length}catch(e){return void 0}}function n(t){var n=this.params,r=this.metrics;if(!this.ended){this.ended=!0;for(var i=0;u>i;i++)t.removeEventListener(s[i],this.listener,!1);if(!n.aborted){if(r.duration=(new Date).getTime()-this.startTime,4===t.readyState){n.status=t.status;var a=t.responseType,d="arraybuffer"===a||"blob"===a||"json"===a?t.response:t.responseText,f=e(d);if(f&&(r.rxSize=f),this.sameOrigin){var c=t.getResponseHeader("X-NewRelic-App-Data");c&&(n.cat=c.split(", ").pop())}}else n.status=0;r.cbTime=this.cbTime,o("xhr",[n,r])}}}function r(t,e){var n=i(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.sameOrigin=n.sameOrigin}t("loader").features.push("xhr");var o=t("handle"),i=t(1),a=t(5),s=["load","error","abort","timeout"],u=s.length,d=t(2);t(3),t(4),a.on("new-xhr",function(){this.totalCbs=0,this.called=0,this.cbTime=0,this.end=n,this.ended=!1,this.xhrGuids={}}),a.on("open-xhr-start",function(t){this.params={method:t[0]},r(this,t[1]),this.metrics={}}),a.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid)}),a.on("send-xhr-start",function(t,n){var r=this.metrics,o=t[0],i=this;if(r&&o){var d=e(o);d&&(r.txSize=d)}this.startTime=(new Date).getTime(),this.listener=function(t){try{"abort"===t.type&&(i.params.aborted=!0),("load"!==t.type||i.called===i.totalCbs&&(i.onloadCalled||"function"!=typeof n.onload))&&i.end(n)}catch(e){try{a.emit("internal-error",e)}catch(r){}}};for(var f=0;u>f;f++)n.addEventListener(s[f],this.listener,!1)}),a.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),a.on("xhr-load-added",function(t,e){var n=""+d(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),a.on("xhr-load-removed",function(t,e){var n=""+d(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),a.on("addEventListener-end",function(t,e){e instanceof XMLHttpRequest&&"load"===t[0]&&a.emit("xhr-load-added",[t[1],t[2]],e)}),a.on("removeEventListener-end",function(t,e){e instanceof XMLHttpRequest&&"load"===t[0]&&a.emit("xhr-load-removed",[t[1],t[2]],e)}),a.on("fn-start",function(t,e,n){e instanceof XMLHttpRequest&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=(new Date).getTime()))}),a.on("fn-end",function(t,e){this.xhrCbStart&&a.emit("xhr-cb-time",[(new Date).getTime()-this.xhrCbStart,this.onload,e],e)})}window.XMLHttpRequest&&XMLHttpRequest.prototype&&XMLHttpRequest.prototype.addEventListener&&!/CriOS/.test(navigator.userAgent)&&e()},{1:8,2:11,3:3,4:6,5:1,handle:"D5DuLP",loader:"G9z0Bl"}],8:[function(t,e){e.exports=function(t){var e=document.createElement("a"),n=window.location,r={};e.href=t,r.port=e.port;var o=e.href.split("://");return!r.port&&o[1]&&(r.port=o[1].split("/")[0].split(":")[1]),r.port&&"0"!==r.port||(r.port="https"===o[0]?"443":"80"),r.hostname=e.hostname||n.hostname,r.pathname=e.pathname,"/"!==r.pathname.charAt(0)&&(r.pathname="/"+r.pathname),r.sameOrigin=!e.hostname||e.hostname===document.domain&&e.port===n.port&&e.protocol===n.protocol,r}},{}],handle:[function(t,e){e.exports=t("D5DuLP")},{}],D5DuLP:[function(t,e){function n(t,e){var n=r[t];return n?n.apply(this,e):(o[t]||(o[t]=[]),void o[t].push(e))}var r={},o={};e.exports=n,n.queues=o,n.handlers=r},{}],11:[function(t,e){function n(t){if(!t||"object"!=typeof t&&"function"!=typeof t)return-1;if(t===window)return 0;if(o.call(t,"__nr"))return t.__nr;try{return Object.defineProperty(t,"__nr",{value:r,writable:!0,enumerable:!1}),r}catch(e){return t.__nr=r,r}finally{r+=1}}var r=1,o=Object.prototype.hasOwnProperty;e.exports=n},{}],loader:[function(t,e){e.exports=t("G9z0Bl")},{}],G9z0Bl:[function(t,e){function n(){var t=p.info=NREUM.info;if(t&&t.agent&&t.licenseKey&&t.applicationID&&u&&u.body){p.proto="https"===c.split(":")[0]||t.sslForHttp?"https://":"http://",a("mark",["onload",i()]);var e=u.createElement("script");e.src=p.proto+t.agent,u.body.appendChild(e)}}function r(){"complete"===u.readyState&&o()}function o(){a("mark",["domContent",i()])}function i(){return(new Date).getTime()}var a=t("handle"),s=window,u=s.document,d="addEventListener",f="attachEvent",c=(""+location).split("?")[0],p=e.exports={offset:i(),origin:c,features:[]};u[d]?(u[d]("DOMContentLoaded",o,!1),s[d]("load",n,!1)):(u[f]("onreadystatechange",r),s[f]("onload",n)),a("mark",["firstbyte",i()])},{handle:"D5DuLP"}],14:[function(t,e){function n(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(0>o?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=n},{}],15:[function(t,e){function n(t,e,r,s){function nrWrapper(){try{var n,a=u(arguments),d=this,f=r&&r(a,d)||{}}catch(c){i([c,"",[a,d,s],f])}o(e+"start",[a,d,s],f);try{return n=t.apply(d,a)}catch(p){throw o(e+"err",[a,d,p],f),p}finally{o(e+"end",[a,d,n],f)}}return a(t)?t:(e||(e=""),nrWrapper[n.flag]=!0,nrWrapper)}function r(t,e,r,o){r||(r="");var i,s,u,d="-"===r.charAt(0);for(u=0;u<e.length;u++)s=e[u],i=t[s],a(i)||(t[s]=n(i,d?s+r:r,o,s,t))}function o(t,e,n){try{s.emit(t,e,n)}catch(r){i([r,t,e,n])}}function i(t){try{s.emit("internal-error",t)}catch(e){}}function a(t){return!(t&&"function"==typeof t&&t.apply&&!t[n.flag])}var s=t(1),u=t(2);e.exports=n,n.inPlace=r,n.flag="nr@wrapper"},{1:1,2:14}]},{},["G9z0Bl",2,7]);</script>
  <meta name="refspec" content="d96e331">
  <title>Public misinformed about seal of approval from US drug agency </title>
  <meta content="authenticity_token" name="csrf-param" />
<meta content="T8Dlii18HdlRovO6UvKSvSUrgnDREuksWuU4fsRKa3w=" name="csrf-token" />

  <link href="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/assets/application-0017586140acaf2f1f0fd35f576d18b2.css" media="screen" rel="stylesheet" />
  

  <!--[if lt IE 9]><script src="/javascripts/vendor/shim.js"></script><![endif]-->

  <!--[if IE 7]><link href="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/assets/ie/ie7-3deeea9dc86c70a99aeb2ddef61abc06.css" media="screen" rel="stylesheet" /><![endif]-->
  <!--[if IE 8]><link href="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/assets/ie/ie8-0cf11a030871be5890a97e8b77f1bd8c.css" media="screen" rel="stylesheet" /><![endif]-->

  <link href="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/assets/print-4e002e0145c9228c7100c53deb0894ff.css" media="print" rel="stylesheet" />

  <link rel="apple-touch-icon-precomposed" href="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/assets/ios-logo-41e10a2c40d16df167b336b21219110f.png">
  <link rel="shortcut icon" href="/favicon.ico">
  <meta property="fb:app_id" content="127105130696839">
  <script charset="utf-8">
  if (/iPad/.test(navigator.userAgent)) {
    // 972px layout + 20px gutter on left & right.
    document.write('<meta name="viewport" content="width=1012">');
  } else {
    document.write('<meta name="viewport" content="width=device-width, initial-scale=1">');
  }
</script>

    
    <meta content="Between 2005 and 2011, nearly half of all new drug formulations in the US were approved without companies having to demonstrate a tangible benefit, such as relieving disease symptoms, extending life, or…" name="description" />
<meta content="20140122" name="pubdate" />
<meta content="analysis" name="searchtype" />
<meta content="http://theconversation.com/public-misinformed-about-seal-of-approval-from-us-drug-agency-22319" name="original-source" />

    <meta content="The Conversation" property="og:site_name" />
<meta content="Public misinformed about seal of approval from US drug agency " property="og:title" />
<meta content="Between 2005 and 2011, nearly half of all new drug formulations in the US were approved without companies having to demonstrate a tangible benefit, such as relieving disease symptoms, extending life, or…" property="og:description" />
<meta content="article" property="og:type" />
<meta content="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/files/39673/width668/9yqbgkzx-1390393046.jpg" property="og:image" />
<meta content="2014-02-25T00:29Z" property="og:updated_time" />
<meta content="http://theconversation.com/public-misinformed-about-seal-of-approval-from-us-drug-agency-22319" property="og:url" />
<meta content="https://www.facebook.com/ConversationUK" property="article:publisher" />

    <meta content="summary_large_image" name="twitter:card" />
<meta content="@ConversationUK" name="twitter:site" />


    
    <link href="http://theconversation.com/public-misinformed-about-seal-of-approval-from-us-drug-agency-22319" rel="canonical" />

  
<script type="text/javascript">
  var _gaq = _gaq || [];
  _gaq.push(['_setAccount', "UA-21436757-1"]);

  _gaq.push(['_setCustomVar', 2, 'CommissioningRegion', 'uk', 3]);
_gaq.push(['_setCustomVar', 3, 'ContentType', 'analysis', 3]);
_gaq.push(['_setCustomVar', 5, 'RegionCode', 'uk', 3]);
_gaq.push(['_setCustomVar', 1, 'UserType', 'Reader', 2]);


  _gaq.push(['_deleteCustomVar', 4]);

    _gaq.push(['_trackPageview']);
    (function() {
      var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
      ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
      var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
    })();
</script>

</head>
<body class="application region_uk content content-show content content-show presenting-article analysis">
  
    <div id="sm-sidebar">
  <div id="sm-sidebar-content">
    <h3>Sections <span id="sm-sidebar-close-button" class="icon-delete"></span></h3>
    <ul>
        <li class="home-page ">
          <a class="" href="/uk">Home<span class="icon-chevron-right"></span></a>
        </li>
        <li class="arts ">
          <a class="" href="/uk/arts">Arts <span><span title="and">+</span> Culture</span><span class="icon-chevron-right"></span></a>
        </li>
        <li class="business ">
          <a class="" href="/uk/business">Business <span><span title="and">+</span> Economy</span><span class="icon-chevron-right"></span></a>
        </li>
        <li class="education ">
          <a class="" href="/uk/education">Education<span class="icon-chevron-right"></span></a>
        </li>
        <li class="environment ">
          <a class="" href="/uk/environment">Environment <span><span title="and">+</span> Energy</span><span class="icon-chevron-right"></span></a>
        </li>
        <li class="health ">
          <a class="active" href="/uk/health">Health <span><span title="and">+</span> Medicine</span><span class="icon-chevron-right"></span></a>
        </li>
        <li class="politics ">
          <a class="" href="/uk/politics">Politics <span><span title="and">+</span> Society</span><span class="icon-chevron-right"></span></a>
        </li>
        <li class="technology ">
          <a class="" href="/uk/technology">Science <span><span title="and">+</span> Technology</span><span class="icon-chevron-right"></span></a>
        </li>
        <li class="world-cup-2014 last">
          <a class="" href="/uk/world-cup-2014">World Cup<span class="icon-chevron-right"></span></a>
        </li>
    </ul>


    <h3>Services</h3>
    <ul>
      <li>
        <a href="/uk/events">
          Events <span class="icon-chevron-right"></span>
</a>      </li>
      <li>
        <a href="/uk/newsletter">
          Newsletter <span class="icon-chevron-right"></span>
</a>      </li>
      <li id="google-currents-link">
        <a href="http://www.google.com/newsstand/s/editions/CAowro6aAg">Read on Google Play<span class="icon-chevron-right"></span></a>
      </li>
    </ul>


    <h3>Information</h3>
    <ul>
      <li><a class="" href="/uk/who_we_are">Who we are <span class="icon-chevron-right"></span></a></li>
      <li><a class="" href="/uk/our_charter">Our charter <span class="icon-chevron-right"></span></a></li>
      <li><a class="" href="/uk/our_team">Our team <span class="icon-chevron-right"></span></a></li>
      <li><a class="" href="/uk/partners">Partners and funders <span class="icon-chevron-right"></span></a></li>
      <li><a class="" href="/institutions">Contributing institutions <span class="icon-chevron-right"></span></a></li>
      <li><a class="" href="/uk/contact_us">Contact us <span class="icon-chevron-right"></span></a></li>
      <li><a class="" href="/uk/privacy_policy">Privacy policy <span class="icon-chevron-right"></span></a></li>
      <li><a class="" href="/uk/terms_and_conditions">Terms and conditions <span class="icon-chevron-right"></span></a></li>
      <li><a class="" href="/uk/corrections">Corrections <span class="icon-chevron-right"></span></a></li>
    </ul>
  </div>
</div>


  <div id="page-wrapper">


    <div id="sm-topbar">

  <div>
    <span id="sm-topbar-menu-button" class="icon-menu"></span>
  </div>

  <div id="sm-region-select">
    <div>
      <span id="sm-region-current">
        <span class="code">UK</span>
        <span class="name">United Kingdom</span>
      </span>
      <span class="icon-caret-down"></span>
    </div>
    <select id="sm-region-select-dropdown">
      <option data-code="AU" value="/au">
        Australia
      </option>
      <option data-code="UK" value="/uk" selected="selected">
        United Kingdom
      </option>
    </select>
  </div>

  <div>
    <span id="sm-topbar-search-button" class="icon-search"></span>
  </div>

  <div id="sm-search">
    <form action="/search">
      <input type="text" name="q" placeholder="Search analysis, academics…">
      <button type="submit" class="button active"><span class="icon-search"></span></button>
    </form>
  </div>

  <div id="sm-overlay"></div>

</div>

    <section id="topbar">
  <div class="wrapper clearfix">

    <div id="edition-selector">
      <ul>
        <li><span>Edition:</span></li>
        <li class="region au">
          <a href="/au" title="Australia">
            AU
</a>        </li>
        <li class="region uk active">
          <a href="/uk" title="United Kingdom">
            UK
</a>        </li>
      </ul>
    </div>

    <nav id="site-nav">
      <ul>
        

        <li class="tc-events">
          <a href="/uk/events">Events</a>
        </li>

        <li class="newsletter">
          <a href="/uk/newsletter" title="Sign up to receive our daily email newsletter">Newsletter</a>
        </li>

        <li class="social-media elsewhere">
          <a href="https://www.facebook.com/ConversationUK" title="The Conversation on Facebook"><i class="icon-facebook"></i></a>
          <a href="https://twitter.com/ConversationUK" title="The Conversation on Twitter"><i class="icon-twitter"></i></a>
          <a class="rss" href="/uk/our_feeds" title="The Conversation&#39;s Feeds"><i class="icon-rss"></i></a>
        </li>
      </ul>
    </nav>

    <nav class="account-nav">
        <ul class="auth">
          <li>
            <a href="/become-an-author">Become an author</a>
          </li>
          <li>
            <a href="https://theconversation.com/sign_up?return_to=%2Fpublic-misinformed-about-seal-of-approval-from-us-drug-agency-22319">Sign up as a reader</a>
          </li>
          <li>
            <a href="/sign_in?return_to=%2Fpublic-misinformed-about-seal-of-approval-from-us-drug-agency-22319">Sign in</a>
          </li>
        </ul>
    </nav>
  </div>
</section>


    <div id="outer">
      
        <div class="wrapper nocontent">
          <header id="masthead" class="clearfix">
  <a href="/uk" id="home-link">
    <img alt="The Conversation" src="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/assets/masthead-32e0108d99ee2c25e357237aa8d3390a.svg" />
</a>
  <form action="/search" method="get" class="search-form" id="search">
    <fieldset>
  <legend>Search</legend>
  <div class="row">
    <div class="input-wrapper">
      <label for="q"><i class="icon-search"></i></label>
      <input id="q" name="q" placeholder="Search analysis, research, academics…" type="text" value="" />
    </div>
    <button type="submit" class="button" value="Search"></button>
  </div>
</fieldset>

  </form>

  <div id="tagline" class="left clear-left">
    <ul>
      <li class="active"><span>Academic rigour, journalistic flair</span></li>
      <li><span>Latest ideas and research</span></li>
      <li><span>From the curious to the serious</span></li>
    </ul>
  </div>
</header>

          <nav id="primary" class=" nocontent">
  <ol>
      <li class="arts ">
        <a class="" href="/uk/arts" title="Arts + Culture">Arts <span><span title="and">+</span> Culture</span></a>
      </li>
      <li class="business ">
        <a class="" href="/uk/business" title="Business + Economy">Business <span><span title="and">+</span> Economy</span></a>
      </li>
      <li class="education ">
        <a class="" href="/uk/education" title="Education">Education</a>
      </li>
      <li class="environment ">
        <a class="" href="/uk/environment" title="Environment + Energy">Environment <span><span title="and">+</span> Energy</span></a>
      </li>
      <li class="health ">
        <a class="current" href="/uk/health" title="Health + Medicine">Health <span><span title="and">+</span> Medicine</span></a>
      </li>
      <li class="politics ">
        <a class="" href="/uk/politics" title="Politics + Society">Politics <span><span title="and">+</span> Society</span></a>
      </li>
      <li class="technology ">
        <a class="" href="/uk/technology" title="Science + Technology">Science <span><span title="and">+</span> Technology</span></a>
      </li>
      <li class="world-cup-2014 last">
        <a class="" href="/uk/world-cup-2014" title="World Cup">World Cup</a>
      </li>
  </ol>
</nav>

            <section id="hot-topics" class=" clearfix nocontent">
    <h3>
      <a href="/topics">Follow Topics</a>
    </h3>

    <ol>
        <li>
          <a class="nocontent" data-slug="phone-hacking-trial" href="/topics/phone-hacking-trial">Phone hacking trial</a>
        </li>
        <li>
          <a class="nocontent" data-slug="al-jazeera" href="/topics/al-jazeera">Al Jazeera</a>
        </li>
        <li>
          <a class="nocontent" data-slug="iraq" href="/topics/iraq">Iraq</a>
        </li>
        <li>
          <a class="nocontent" data-slug="wimbledon-2014" href="/topics/wimbledon-2014">Wimbledon 2014</a>
        </li>
        <li>
          <a class="nocontent" data-slug="trojan-horse" href="/topics/trojan-horse">Trojan Horse</a>
        </li>
        <li>
          <a class="nocontent" data-slug="world-cup-2014" href="/topics/world-cup-2014">World Cup 2014</a>
        </li>
        <li>
          <a class="nocontent" data-slug="hard-evidence" href="/topics/hard-evidence">Hard Evidence</a>
        </li>
        <li>
          <a class="nocontent" data-slug="scotland" href="/topics/scotland">Scotland</a>
        </li>
        <li>
          <a class="nocontent" data-slug="digital-economy" href="/topics/digital-economy">Digital economy</a>
        </li>
    </ol>
  </section>

        </div>

      


      
      <div id="page" class="wrapper">
        <div id="body" class="clearfix">
          


<article id="article" class="hentry clearfix" data-id="22319" itemscope itemtype="http://schema.org/Article">
  
    <header class="grid-prepend-four grid-twelve">
      <time content="2014-01-22T15:44Z" datetime="2014-01-22T15:44+0000" itemprop="datePublished" pubdate="pubdate">22 January 2014, 3.44pm GMT</time>
      <h1 class="entry-title grid-eight instapaper_title" itemprop="name">
        Public misinformed about seal of approval from US drug&nbsp;agency
      </h1>
    </header>

  
    <div class="entry-summary" style="text-indent: 100%; white-space: nowrap; overflow: hidden;">
      <p>Between 2005 and 2011, nearly half of all new drug formulations in the US were approved without companies having to demonstrate a tangible benefit, such as relieving disease symptoms, extending life, or…</p>
    </div>


  <aside id="meta" class="grid-four">
    
      <section id="authors" class="module">
  <h4>Author</h4>
  <ol class="semantic">
    <li class="vcard author-avatar large" id="author-114295" itemprop="author" itemscope itemtype="http://schema.org/Person">
        <a href="/profiles/efthimios-parasidis-114295" rel="author">
    <img alt="" height="54" itemprop="image" src="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/avatars/114295/thumb54/RackMultipart20140122-11519-1ofxtkp.jpg" width="54" />
    <h3 class="fn">
      <span itemprop="name">Efthimios Parasidis</span>
      
    </h3>
    <p>
      <span class="role">Assistant Professor of Law at Ohio State University</span>
    </p>
</a>
    </li>
</ol>

</section>

      
      
      
        <section id="disclosure-statement" class="module">
    <h4>Disclosure Statement</h4>
      <p>Efthimios Parasidis does not work for, consult to, own shares in or receive funding from any company or organisation that would benefit from this article, and has no relevant affiliations.</p>
  </section>

  <section id="funding" class="module nocontent">
  <p>
    <strong>The Conversation is funded by the following universities:</strong> Aberdeen, Birmingham, Bradford, Bristol, Cardiff, City, Durham, Glasgow Caledonian, Goldsmiths, Lancaster, Leeds, Liverpool, Nottingham, The Open University, Queen's University Belfast, Salford, Sheffield, Surrey, UCL and Warwick.
  </p>

  <p>
    <strong>It also receives funding from:</strong> Hefce, Hefcw, SAGE, SFC, RCUK, The Nuffield Foundation, The Wellcome Trust, Esmée Fairbairn Foundation and The Alliance for Useful Evidence
  </p>
</section>



    
      

    
      
    <section class="jobs-events-list clearfix">
      <h4>Events</h4>
      
  <ul>
      <li class="event">
        <p>
          <a href="/uk/events/the-student-connections-online-conference-2014-637" rel="nofollow" target="_blank">
            <span class="name">The Student Connections Online Conference 2014 </span>

              &mdash;
              <span class="institution">The Open University</span>

              &mdash;
              <span class="location">Milton Keynes</span>
</a>        </p>
      </li>
      <li class="event">
        <p>
          <a href="/uk/events/5th-international-conference-researching-childrens-everyday-lives-socio-cultural-contexts-629" rel="nofollow" target="_blank">
            <span class="name">5th International Conference, &#39;Researching Children&#39;s Everyday Lives: socio-cultural contexts&#39;</span>

              &mdash;
              <span class="institution">University of Sheffield</span>

              &mdash;
              <span class="location">Sheffield</span>
</a>        </p>
      </li>
      <li class="event">
        <p>
          <a href="/uk/events/conroy-maddox-and-birmingham-surrealism-243" rel="nofollow" target="_blank">
            <span class="name">Conroy Maddox and Birmingham Surrealism</span>

              &mdash;
              <span class="institution">University of Birmingham</span>

              &mdash;
              <span class="location">Birmingham</span>
</a>        </p>
      </li>
      <li class="event">
        <p>
          <a href="/uk/events/gcu-annual-research-day-2014-298" rel="nofollow" target="_blank">
            <span class="name">GCU Annual Research Day 2014</span>

              &mdash;
              <span class="institution">Glasgow Caledonian University</span>

              &mdash;
              <span class="location">Glasgow City</span>
</a>        </p>
      </li>
  </ul>

  <a class="view-more" href="/uk/events">
    <i class="icon-the-conversation"></i>
    <span class="action">More Events</span>
</a>
    </section>

  </aside>

  <div class="grid-twelve grid-last content-wrapper">
    <div class="grid-twelve instapaper_body">
      <div class="content entry-content">
        

            <figure class="lead-image grid-eight grid-last">
    <img alt="" data-id="39673" itemprop="image" src="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/files/39673/article/width668/w873ssss-1390393091.jpg" />
      <figcaption>
        Signed, sealed, delivered, not yours.
        <span class="attribution"><span class="source">Adactio</span></span>
      </figcaption>
  </figure>


          <div class="body grid-eight" itemprop="articleBody">
            <p>Between 2005 and 2011, nearly half of all new drug formulations in the US were approved without companies having to demonstrate a tangible benefit, such as relieving disease symptoms, extending life, or improving someone’s ability to go about normal activities.</p>

<p>What patients really want is evidence that the drug they are taking will actually improve their condition. But the FDA, the American drug regulator, doesn’t routinely <a href="http://content.healthaffairs.org/content/24/1/67.full">consider this</a> for new molecular entities (NMEs) – drugs that have innovative chemical structures that have never been marketed before.</p>

<p>The findings come <a href="http://jama.jamanetwork.com/article.aspx?articleid=1817794">in a new paper</a> by Nicholas Downing of Yale University and colleagues, part of a series on the drug approval process published in the Journal of the American Medical Association (JAMA), that found there was wide variation in the quality of evidence considered by the FDA. They also found that nearly two out of five drugs approved by the FDA was brought to market after a single pivotal trial.</p>

<p>A <a href="http://jama.jamanetwork.com/article.aspx?articleid=1817796">second paper</a> in the series documented the lack of data required by the FDA when it considers approvals for medical devices – the study found that only 14% of high-risk medical devices, such as pacemakers and other cardiovascular implants, were assessed in one randomised control trial.</p>

<p>Both studies strongly suggest that the FDA is approving products that may not have accurate risk-benefit profiles, which could place patients at risk.</p>

<h2>Sleeping watchdog?</h2>

<p>While patients and physicians rely on the FDA to serve as an appropriate gatekeeper and watchdog, opinion polls reveal the public is misinformed as to what the FDA seal of approval actually means. For example, a national randomised trial conducted in 2011 <a href="https://archinte.jamanetwork.com/article.aspx?articleid=1105910&amp;link=xref">found that</a> 39% of US adults believe the FDA approves only “extremely effective” drugs, and 25% believe the agency only approves drugs that do not have serious side effects.</p>

<p>In addition to debunking these commonly held myths, the Downing paper is part of a long line of comprehensive studies that have highlighted <a href="http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1964025">the limitations</a> of the FDA’s review process for new drugs before they hit the market.</p>

<p>Because pre-market studies are limited in duration and scope, they often fail to capture later adverse events, or adverse effects that only happen to a small percentage or sub-population of patients. At the same time, pre-market studies often include research subjects who are not representative of “real-world” patients. For example, studies typically don’t include patients who are taking multiple medications.</p>

<p>The findings also affirm what commentators and FDA Commissioners have long argued – that the FDA should take a more proactive role in reviewing drugs and medical devices once they hit the market, to make sure adverse events are logged and considered.</p>

<p>No one wants an approval process <a href="https://theconversation.com/stopping-23andme-will-only-delay-the-revolution-medicine-needs-20743">that drags</a> on for a long time. So when it comes to catching later problems, the only meaningful alternative is to require that drug and medical device manufacturers actively review post-market data and report their findings to the FDA – something that needs manufacturers to actively engage with.</p>

<h2>Inside the FDA</h2>

<p>Since the 1960s, the total number of drugs approved <a href="https://theconversation.com/why-there-may-be-fewer-truly-new-drugs-hitting-the-market-22315">has been falling</a> on average, according to data collated by The Conversation. This is happening at the same time as the cost of research and development is going up. In <a href="http://jama.jamanetwork.com/article.aspx?articleid=1817795">another study</a> in the JAMA series, six FDA scientists looked at the reasons why approvals for drugs might be delayed or denied. According to the paper, between 2000 and 2012 a half of NMEs were approved when first submitted to the agency and nearly 75% were ultimately approved. Some of the reasons why new compounds failed to earn FDA approval included inadequate performance and problems with doses.</p>

<p>It’s a hugely important paper because information from the FDA on why drugs aren’t approved is limited, due to <a href="http://jama.jamanetwork.com/article.aspx?articleid=1817770">data sharing issues</a> (despite <a href="http://www.fda.gov/aboutfda/transparency/publicdisclosure/executivesummary/ucm210718.htm#productapps">recommendations</a> from its own transparency taskforce).</p>

<p>The study is sure to provide meaningful guidance to pharmaceutical companies as they contemplate, prepare or conduct pre-market studies. At the same time, however, the article raises complex questions as to the proper role of the FDA as regulator, industry collaborator, and promoter of public health. In many respects the FDA and industry are collaborators – industry’s responses to new regulations are taken seriously by the agency, and lobby groups have long had significant influence over the legislation that sets the legal limits of FDA’s authority. Yet, the agency’s primary mission is to ensure that marketed products are safe and effective, though the FDA characterises itself as a public health agency <a href="http://www.nejm.org/doi/full/10.1056/NEJMp0903764">that must</a> “promote health, prevent illness, and prolong life”.</p>

<p>As Marcia Angell, former editor of the New England Journal of Medicine, <a href="http://www.nybooks.com/articles/archives/2010/sep/30/agency-can-be-dangerous/">has observed</a>, “there is growing evidence that … [the FDA] has become the servant of the industry it regulates.”</p>

<p>Taken together, the articles support calls for the FDA to be more robust in the surveillance of marketed drugs and medical products. Simply stated, we need to know if the products we are using actually work. As the Downing study shows, the FDA’s pre-market review process isn’t clear on this and the public remain none the wiser.</p>

<hr>
<p><em>Related: <a href="https://theconversation.com/why-there-may-be-fewer-truly-new-drugs-hitting-the-market-22315">Why there may be fewer truly new drugs hitting the market</a></em></p>
            <script async="async" data-counter="https://counter.theconversation.edu.au/content/22319/count" id="theconversation_tracker_hook" src="https://theconversation.com/javascripts/lib/content_tracker_hook.js"></script>

          </div>

        <aside id="related-content" class="grid-three grid-prepend-one grid-last">
            <a class="favourite button subtle signed-out" href="/sign_in?return_to=%2Fpublic-misinformed-about-seal-of-approval-from-us-drug-agency-22319">
    <i class="icon-favourite"></i> Sign in to Favourite
</a>
          
            <a href="#comments" class="comment-count button subtle">
              <i class="icon-comments"></i>
              <span class="number-of-comments">4</span> Comments
            </a>
          
            <div class="share social-media clearfix module vertical">
  <ul class="semantic">
    <li class="republish">
      <a href="#republish" class="button subtle" id="steal-button" data-republish="/share/public-misinformed-about-seal-of-approval-from-us-drug-agency-22319">
        <i class="icon-republish"></i> Republish
      </a>
    </li>
    <li class="email">
      <a class="button subtle" href="mailto:?body=Hi%0A%0AI%20found%20this%20article%20on%20http%3A%2F%2Ftheconversation.com%20that%20you%20might%20like%3A%20%22Public%20misinformed%20about%20seal%20of%20approval%20from%20US%20drug%20agency%20%22%20%0A%0Ahttp%3A%2F%2Ftheconversation.com%2Fpublic-misinformed-about-seal-of-approval-from-us-drug-agency-22319&amp;subject=Public%20misinformed%20about%20seal%20of%20approval%20from%20US%20drug%20agency%20"><i class="icon-email"></i> Email</a>
    </li>


    <li class="twitter">
      <a class="button subtle twitter-button" href="http://twitter.com/intent/tweet?text=Public+misinformed+about+seal+of+approval+from+US+drug+agency+&amp;url=http%3A%2F%2Ftheconversation.com%2Fpublic-misinformed-about-seal-of-approval-from-us-drug-agency-22319&amp;utm_campaign=article-top&amp;utm_medium=tweetbutton&amp;utm_source=twitter&amp;via=ConversationUK" target="_blank"><i class="icon-twitter"></i><span> Tweet</span></a><span class="data-count">121</span>
    </li>
    <li class="facebook">
      <a class="button subtle facebook-button" data-url="http://theconversation.com/public-misinformed-about-seal-of-approval-from-us-drug-agency-22319" href="http://www.facebook.com/sharer.php?u=http%3A%2F%2Ftheconversation.com%2Fpublic-misinformed-about-seal-of-approval-from-us-drug-agency-22319&amp;utm_medium=facebookbutton&amp;utm_source=facebook" target="_blank"><i class="icon-facebook"></i><span> Share</span></a>
    </li>
    <li class="linkedin">
      <a class="button subtle linkedin-button" data-url="http://theconversation.com/public-misinformed-about-seal-of-approval-from-us-drug-agency-22319" href="http://www.linkedin.com/shareArticle?mini=true&amp;source=The+Conversation&amp;summary=Between+2005+and+2011%2C+nearly+half+of+all+new+drug+formulations+in+the+US+were+approved+without+companies+having+to+demonstrate+a+tangible+benefit%2C+such+as+relieving+disease+symptoms%2C+extending+lif...&amp;title=Public+misinformed+about+seal+of+approval+from+US+drug+agency+&amp;url=http%3A%2F%2Ftheconversation.com%2Fpublic-misinformed-about-seal-of-approval-from-us-drug-agency-22319&amp;utm_medium=linkedinbutton&amp;utm_source=linkedin" target="_blank"><i class="icon-linkedin"></i><span> Share</span></a>
    </li>
    <li class="reddit">
      <a class="button subtle reddit-button" data-url="http://theconversation.com/public-misinformed-about-seal-of-approval-from-us-drug-agency-22319" href="http://www.reddit.com/submit?title=Public+misinformed+about+seal+of+approval+from+US+drug+agency+&amp;url=http%3A%2F%2Ftheconversation.com%2Fpublic-misinformed-about-seal-of-approval-from-us-drug-agency-22319" target="_blank"><i class="icon-reddit"></i><span> Reddit this!</span></a>
    </li>
  </ul>
</div>

          
              <section id="related_topics" class="module">
    <h4>Tags</h4>
    <p>
      <a href="/topics/fda">FDA</a>, <a href="/topics/jama">JAMA</a>
    </p>
  </section>

          
              <section class="related module nocontent">
    <h4>Related articles</h4>
    <nav class="article-list">
        <article class="article">
          <a href="/genes-predispose-obesity-but-its-fullness-that-makes-you-fat-23335">
              <img alt="J6tdycks 1392647007" src="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/files/41707/width240x240/j6tdycks-1392647007.jpg" />
            <time datetime="2014-02-17" pubdate="pubdate">17 February 2014</time>
            Genes predispose obesity but it&rsquo;s fullness that makes you&nbsp;fat
</a>        </article>
        <article class="article">
          <a href="/how-the-dallas-buyers-club-changed-hiv-treatment-in-the-us-22664">
              <img alt="Gtvp9m49 1391533353" src="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/files/40668/width240x240/gtvp9m49-1391533353.jpg" />
            <time datetime="2014-02-06" pubdate="pubdate">6 February 2014</time>
            How the Dallas Buyers Club changed HIV treatment in the&nbsp;US
</a>        </article>
        <article class="article">
          <a href="/why-there-may-be-fewer-truly-new-drugs-hitting-the-market-22315">
              <img alt="D9hs5px8 1390389136" src="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/files/39665/width240x240/d9hs5px8-1390389136.jpg" />
            <time datetime="2014-01-22" pubdate="pubdate">22 January 2014</time>
            Why there may be fewer truly new drugs hitting the&nbsp;market
</a>        </article>
        <article class="article">
          <a href="/it-is-game-over-for-23andme-and-rightly-so-20744">
              <img alt="Jw767d86 1385476072" src="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/files/36187/width240x240/jw767d86-1385476072.jpg" />
            <time datetime="2013-11-26" pubdate="pubdate">26 November 2013</time>
            It is game over for 23andMe, and rightly&nbsp;so
</a>        </article>
        <article class="article">
          <a href="/stopping-23andme-will-only-delay-the-revolution-medicine-needs-20743">
              <img alt="Mr853gq7 1385415686" src="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/files/36072/width240x240/mr853gq7-1385415686.jpg" />
            <time datetime="2013-11-25" pubdate="pubdate">25 November 2013</time>
            Stopping 23andMe will only delay the revolution medicine&nbsp;needs
</a>        </article>
    </nav>
  </section>

        </aside>

      </div>
    </div>
  </div>

</article>

<div class="grid-prepend-four grid-eight grid-last">
  
    
    <a class="favourite button subtle signed-out" href="/sign_in?return_to=%2Fpublic-misinformed-about-seal-of-approval-from-us-drug-agency-22319">
    <i class="icon-favourite"></i> Sign in to Favourite
</a>
  
    <div class="share social-media clearfix module horizontal">
  <ul class="semantic">
    <li class="republish">
      <a href="#republish" class="button subtle" id="steal-button" data-republish="/share/public-misinformed-about-seal-of-approval-from-us-drug-agency-22319">
        <i class="icon-republish"></i> Republish
      </a>
    </li>
    <li class="email">
      <a class="button subtle" href="mailto:?body=Hi%0A%0AI%20found%20this%20article%20on%20http%3A%2F%2Ftheconversation.com%20that%20you%20might%20like%3A%20%22Public%20misinformed%20about%20seal%20of%20approval%20from%20US%20drug%20agency%20%22%20%0A%0Ahttp%3A%2F%2Ftheconversation.com%2Fpublic-misinformed-about-seal-of-approval-from-us-drug-agency-22319&amp;subject=Public%20misinformed%20about%20seal%20of%20approval%20from%20US%20drug%20agency%20"><i class="icon-email"></i> Email</a>
    </li>

      </ul>
      <ul class="semantic">

    <li class="twitter">
      <a class="button subtle twitter-button" href="http://twitter.com/intent/tweet?text=Public+misinformed+about+seal+of+approval+from+US+drug+agency+&amp;url=http%3A%2F%2Ftheconversation.com%2Fpublic-misinformed-about-seal-of-approval-from-us-drug-agency-22319&amp;utm_campaign=article-bottom&amp;utm_medium=tweetbutton&amp;utm_source=twitter&amp;via=ConversationUK" target="_blank"><i class="icon-twitter"></i><span> Tweet</span></a><span class="data-count">121</span>
    </li>
    <li class="facebook">
      <a class="button subtle facebook-button" data-url="http://theconversation.com/public-misinformed-about-seal-of-approval-from-us-drug-agency-22319" href="http://www.facebook.com/sharer.php?u=http%3A%2F%2Ftheconversation.com%2Fpublic-misinformed-about-seal-of-approval-from-us-drug-agency-22319&amp;utm_medium=facebookbutton&amp;utm_source=facebook" target="_blank"><i class="icon-facebook"></i><span> Share</span></a>
    </li>
    <li class="linkedin">
      <a class="button subtle linkedin-button" data-url="http://theconversation.com/public-misinformed-about-seal-of-approval-from-us-drug-agency-22319" href="http://www.linkedin.com/shareArticle?mini=true&amp;source=The+Conversation&amp;summary=Between+2005+and+2011%2C+nearly+half+of+all+new+drug+formulations+in+the+US+were+approved+without+companies+having+to+demonstrate+a+tangible+benefit%2C+such+as+relieving+disease+symptoms%2C+extending+lif...&amp;title=Public+misinformed+about+seal+of+approval+from+US+drug+agency+&amp;url=http%3A%2F%2Ftheconversation.com%2Fpublic-misinformed-about-seal-of-approval-from-us-drug-agency-22319&amp;utm_medium=linkedinbutton&amp;utm_source=linkedin" target="_blank"><i class="icon-linkedin"></i><span> Share</span></a>
    </li>
    <li class="reddit">
      <a class="button subtle reddit-button" data-url="http://theconversation.com/public-misinformed-about-seal-of-approval-from-us-drug-agency-22319" href="http://www.reddit.com/submit?title=Public+misinformed+about+seal+of+approval+from+US+drug+agency+&amp;url=http%3A%2F%2Ftheconversation.com%2Fpublic-misinformed-about-seal-of-approval-from-us-drug-agency-22319" target="_blank"><i class="icon-reddit"></i><span> Reddit this!</span></a>
    </li>
  </ul>
</div>

  
    <div id="newsletter-signup" class="newsletter-signup-form">
  <h2>Want to follow <span>The Conversation</span>?</h2>
  <p>Sign up to our <strong>free daily newsletter</strong>.</p>

  <form action="/subscriptions" method="post" class="subscribe">
  <fieldset>
    <label for="subscribe_email">
      Email address
    </label>

    <div class="field-wrapper">
      <input class="email" id="subscribe_email" name="subscribe[email]" placeholder="Your email address" spellcheck="false" type="email" value="" />
      <i class="success">✔</i>
      <i class="icon-delete failure"></i>
      <img alt="Spinner" class="spinner" src="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/assets/spinner-d464c754fbb1d103525a36e72bd0b004.gif" />
    </div>

    <input id="subscribe_location" name="subscribe[location]" type="hidden" value="call-to-action-from-article" />

    <fieldset class="regions">
    <label for="subscribe_au">
      <input class="checkbox_au" id="subscribe_regions_" name="subscribe[regions][]" type="checkbox" value="au" />
      <span class="full_name">Australia</span>
      <span class="short_code">au</span>
    </label>
    <label for="subscribe_uk">
      <input checked="checked" class="checkbox_uk" id="subscribe_regions_" name="subscribe[regions][]" type="checkbox" value="uk" />
      <span class="full_name">United Kingdom</span>
      <span class="short_code">uk</span>
    </label>
</fieldset>


    <input class="button subtle" name="subscribe" type="submit" value="Subscribe" />
  </fieldset>
</form>

</div>

</div>





        </div>
      </div>
          
      <section id="comments">
  <div class="wrapper">

    <h1 class="left grid-prepend-one">Join the conversation</h1>

    <nav id="comments-action" class="right grid-append-one">
      To comment or recommend,
      <a class="reader-auth subtle button" href="/sign_in?return_to=%2Fpublic-misinformed-about-seal-of-approval-from-us-drug-agency-22319%23comments">sign in</a>
      or
      <a class="reader-auth subtle button" href="/sign_up?return_to=%2Fpublic-misinformed-about-seal-of-approval-from-us-drug-agency-22319%23comments">sign up</a>

</nav>


    <header class="divider grid-fifteen">
      <h3 class="comment-count grid-four clear">
        <span class="comment-count-shim">
          <span class="number-of-comments">4</span> Comments <span class="sorted-by">sorted by</span>
        </span>
      </h3>
      <nav class="tabbed-button-group minimal">
        <a class="button comment-sort on" href="/public-misinformed-about-seal-of-approval-from-us-drug-agency-22319">Oldest</a>
        <a class="button comment-sort" href="/public-misinformed-about-seal-of-approval-from-us-drug-agency-22319">Newest</a>
      </nav>
    </header>


      <div id="comment-list" class="grid-prepend-three grid-ten grid-last">
        <ol>
            <li class="  clearfix">
    <article id="comment_295788" class="comment reader    ">
      <div class="grid-prepend-one grid-append-one">
        <header class="meta">
          <div class="recommends">

          </div>

              <section class="attribution author-avatar">
  <img alt="" class="comment avatar" data-src="/assets/author/thumb36_default-4185d450d79cb425909b2ec99c73e4fb.jpg" height="36" src="/assets/author/thumb36_default-4185d450d79cb425909b2ec99c73e4fb.jpg" width="36" />
  <h3 class="fn">
    <a href="/profiles/joseph-christie-114556">JOSEPH CHRISTIE</a>
    
  </h3>

    <p class="title">
      Consultant, Triad Technologies
    </p>
</section>

        </header>

        <section class="comment-body">
    <div class="full-comment" style="">
      <p>While I broadly agree with the views expressed by Efthimios Parasidis in the article, as a scientist who dealt with the FDA ( CDER) while working as Regulatory Affairs Manager in a drug Company in Chicago, I have to say that FDA is sadly under-staffed and over-worked. Especially, with  several hundred small generic  drug manufacturers from all over the world aiming at the profitable US market by submitting the ANDA applications for approval of their products, the very day the patent of a large drug Company ( the originator) has expired, the Agency with limited man power  cannot do its job efficiently. The FDA is nevertheless, doing a commendable job in ordering unsafe and substandard drugs off the shelves of chemists. The case of Ranbaxy Pharmaceuticals is clear proof that FDA’s number one priority is the safety of the people in America.</p>
      <div class="more">
        <time pubdate datetime="2014-01-24T14:10+0000" title="24 January 2014">
          <span>5 months ago</span>
        </time>
        <a class="moderation-control" href="/comments/295788/abuses/new" title="Report comment">report</a>
      </div>
    </div>
</section>

      </div>


    </article>
  </li>
  <li class="  clearfix">
    <article id="comment_295813" class="comment author    ">
      <div class="grid-prepend-one grid-append-one">
        <header class="meta">
          <div class="recommends">

          </div>

              <section class="attribution author-avatar">
  <img alt="" class="comment avatar" data-src="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/avatars/114295/thumb36/RackMultipart20140122-11519-1ofxtkp.jpg" height="36" src="/assets/author/thumb36_default-4185d450d79cb425909b2ec99c73e4fb.jpg" width="36" />
  <h3 class="fn">
    <a href="/profiles/efthimios-parasidis-114295">Efthimios Parasidis</a>
    
  </h3>

    <p class="title">
      Assistant Professor of Law at <a href="/institutions/ohio-state-university">Ohio State University</a>
    </p>
</section>

        </header>

        <section class="comment-body">
      <div class="truncated-comment">
        <p>Joseph - thanks for the comment -- you make some excellent points. I agree with you that one of the key problems is under-funding by the US Congress. In fact, this has been a problem that dates back to the founding of the FDA. Some have argued that the underfunding is deliberate - Congress responds to public health catastrophes (think Vioxx, thalidomide, elixir sulfanilamide) by placing additional responsibilities on the FDA, yet does not provide the agency with funding sufficient to do the job…</p>
        <a class="show-comment" href="#">Read more</a>
      </div>
    <div class="full-comment" style="display:none;">
      <p>Joseph - thanks for the comment -- you make some excellent points. I agree with you that one of the key problems is under-funding by the US Congress. In fact, this has been a problem that dates back to the founding of the FDA. Some have argued that the underfunding is deliberate - Congress responds to public health catastrophes (think Vioxx, thalidomide, elixir sulfanilamide) by placing additional responsibilities on the FDA, yet does not provide the agency with funding sufficient to do the job. Congress can then use the FDA&#39;s inability to &quot;do the job&quot; as a means of cutting future funding or, at the very least, to argue against the benefits of regulation. This is a classic tactic of those elected officials who favor de-regulation, some refer to it as &quot;hollow government syndrome&quot;. I also know many people at the agency, and think very highly of them and the work that they and their colleagues do day in and out. The article of mine that I link to focuses on &quot;legislative failure&quot; not agency failure. I firmly believe that Congress should be held accountable for the FDA&#39;s inability to fulfill its mandate, but also believe that the agency has a duty to inform the public of its limitations so as to provide patients and doctors with accurate information of the products it approves.  </p>
      <div class="more">
        <time pubdate datetime="2014-01-24T17:51+0000" title="24 January 2014">
          <span>5 months ago</span>
        </time>
        <a class="moderation-control" href="/comments/295813/abuses/new" title="Report comment">report</a>
      </div>
    </div>
</section>

      </div>


    </article>
  </li>
  <li class=" has-replies clearfix">
    <article id="comment_296389" class="comment reader    ">
      <div class="grid-prepend-one grid-append-one">
        <header class="meta">
          <div class="recommends">

          </div>

              <section class="attribution author-avatar">
  <img alt="" class="comment avatar" data-src="/assets/author/thumb36_default-4185d450d79cb425909b2ec99c73e4fb.jpg" height="36" src="/assets/author/thumb36_default-4185d450d79cb425909b2ec99c73e4fb.jpg" width="36" />
  <h3 class="fn">
    <a href="/profiles/joseph-christie-114556">JOSEPH CHRISTIE</a>
    
  </h3>

    <p class="title">
      Consultant, Triad Technologies
    </p>
</section>

        </header>

        <section class="comment-body">
      <div class="truncated-comment">
        <p>Efthimios- Funding by  Congress to the various Federal Agencies as well as to the Department of Commerce, which has the fiscal responsibility to SBA (Small Business Administration) depends, generally,  on which political party controls the House .By the very nature of its of  election-based politics and the economic policies of the two parties, either of which can control the Congress,  and, funding to FDA depends very much on who the people of America elected to allocate funds for various projects…</p>
        <a class="show-comment" href="#">Read more</a>
      </div>
    <div class="full-comment" style="display:none;">
      <p>Efthimios- Funding by  Congress to the various Federal Agencies as well as to the Department of Commerce, which has the fiscal responsibility to SBA (Small Business Administration) depends, generally,  on which political party controls the House .By the very nature of its of  election-based politics and the economic policies of the two parties, either of which can control the Congress,  and, funding to FDA depends very much on who the people of America elected to allocate funds for various projects submitted by the FDA.  Your statement, “This is a classic tactic of those elected officials who favor de-regulation,” is a sly reference to the Republican Party, which has, willy-nilly,  controlled the Congress during the past 12 to 16 years. No wonder the efficiency of the FDA has been severely hampered due to reasons pointed out earlier. Even as I am writing this comment, the  Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug products in America. If this not stringent swift action by the watchdog what is it then?</p>
      <div class="more">
        <time pubdate datetime="2014-01-25T15:22+0000" title="25 January 2014">
          <span>5 months ago</span>
        </time>
        <a class="moderation-control" href="/comments/296389/abuses/new" title="Report comment">report</a>
      </div>
    </div>
</section>

      </div>


    </article>
        <ol>
            <li class="  clearfix">
    <article id="comment_296391" class="comment author    ">
      <div class="grid-prepend-one grid-append-one">
        <header class="meta">
          <div class="recommends">

          </div>

              <section class="attribution author-avatar">
  <img alt="" class="comment avatar" data-src="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/avatars/114295/thumb36/RackMultipart20140122-11519-1ofxtkp.jpg" height="36" src="/assets/author/thumb36_default-4185d450d79cb425909b2ec99c73e4fb.jpg" width="36" />
  <h3 class="fn">
    <a href="/profiles/efthimios-parasidis-114295">Efthimios Parasidis</a>
    
  </h3>

    <p class="title">
      Assistant Professor of Law at <a href="/institutions/ohio-state-university">Ohio State University</a>
    </p>
</section>

        </header>

          <section class="comment-in-reply-to">
    In reply to <a class="comment-in-reply-to-link" href="#comment_296389">JOSEPH CHRISTIE</a>
  </section>
<section class="comment-body">
      <div class="truncated-comment">
        <p>Under-funding and over-burdening is something both Democrats and Republicans are guilty of. In 1938, when the FDCA was passed, Democrats controlled the House, Senate and White House. The law placed enormous responsibilities on the agency, and experts estimated that a budget of $5-20 million was necessary to fulfill the mandate. For years, the budget was $2,750,000, which was $750,000 more than the pre-FDCA budget--an amount that could not come close to allowing the agency to do its job. Indeed, as…</p>
        <a class="show-comment" href="#">Read more</a>
      </div>
    <div class="full-comment" style="display:none;">
      <p>Under-funding and over-burdening is something both Democrats and Republicans are guilty of. In 1938, when the FDCA was passed, Democrats controlled the House, Senate and White House. The law placed enormous responsibilities on the agency, and experts estimated that a budget of $5-20 million was necessary to fulfill the mandate. For years, the budget was $2,750,000, which was $750,000 more than the pre-FDCA budget--an amount that could not come close to allowing the agency to do its job. Indeed, as a general matter, industry lobbies both parties each year, and their &quot;investment&quot; in lobbying pays off year-in-and-out. Just look at the past two decades and how many unfunded amendments (read, additional responsibilities) were placed on the FDA. Peter Barton Hutt has done the analysis. As for your anecdotal evidence of action, of course, the agency is doing something every day. But, a look at comprehensive studies is revealing and portrays a more accurate picture of the deficiencies. As Kessler and Vladeck report, one study found that, although the FDA mandated post-market studies in 75% of new drug approvals, less than 25% of companies completed the studies, and some never even started them. Of these, no drug was pulled from the market. In addition, according to a study published in 2008 by Psaty and Ray in JAMA, 73% of off-label uses had little or no scientific support. And, Don Light has highlighted the many dubious tactics employed by industry in pre-market clinical trials. While every company is not a bad actor, the evidence is overwhelming and, in my opinion, should be cause for concern. </p>
      <div class="more">
        <time pubdate datetime="2014-01-25T16:12+0000" title="25 January 2014">
          <span>5 months ago</span>
        </time>
        <a class="moderation-control" href="/comments/296391/abuses/new" title="Report comment">report</a>
      </div>
    </div>
</section>

      </div>


    </article>
  </li>

        </ol>
  </li>


        </ol>
    </div>
  </div>
</section>


    </div>

    
      <div id="footers">
        
        <section id="sub-footer">
  <header>
    <div class="wrapper nocontent">
      <h2>The Conversation</h2>
    </div>
  </header>

  <div class="wrapper nocontent">
    <section class="community grid-five">
      <h6>Community</h6>
      <nav>
        <ul>
          <li><a href="/uk/community_standards">Community standards</a></li>
          <li><a href="/uk/republishing_guidelines">Republishing guidelines</a></li>
          <li>
            <a href="/uk/events">
              <i class="icon icon-the-conversation"></i> Events
</a>          </li>
          <li><a href="/uk/our_feeds"><i class="icon icon-rss-non-coloured"></i> Our feeds</a></li>
        </ul>
      </nav>
    </section>

    <section class="company grid-five">
      <h6>Company</h6>
      <nav>
        <ul>
          <li><a href="/uk/who_we_are">Who we are</a></li>
          <li><a href="/uk/our_charter">Our charter</a></li>
          <li><a href="/uk/our_team">Our team</a></li>
          <li><a href="/uk/partners">Partners and funders</a></li>
          <li><a href="/institutions">Contributing institutions</a></li>
          <li><a href="/uk/contact_us">Contact us</a></li>
        </ul>
      </nav>
    </section>

    <section class="contact grid-five">
      <h6>Contact</h6>
      <nav>
        <ul>
          <li><span>Editorial</span> <a href="mailto:uk-editorial@theconversation.com">uk-editorial@theconversation.com</a></li>
          <li><span>Support</span> <a href="mailto:support@theconversation.com">support@theconversation.com</a></li>
        </ul>
      </nav>
      <div class="newsletter-signup-form">
        <h6>Subscribe to our Newsletters</h6>
        <form action="/subscriptions" method="post" class="subscribe">
  <fieldset>
    <label for="subscribe_email">
      Email address
    </label>

    <div class="field-wrapper">
      <input class="email" id="subscribe_email" name="subscribe[email]" placeholder="Your email address" spellcheck="false" type="email" value="" />
      <i class="success">✔</i>
      <i class="icon-delete failure"></i>
      <img alt="Spinner" class="spinner" src="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/assets/spinner-d464c754fbb1d103525a36e72bd0b004.gif" />
    </div>

    <input id="subscribe_location" name="subscribe[location]" type="hidden" value="footer" />

    <fieldset class="regions">
    <label for="subscribe_au">
      <input class="checkbox_au" id="subscribe_regions_" name="subscribe[regions][]" type="checkbox" value="au" />
      <span class="full_name">Australia</span>
      <span class="short_code">au</span>
    </label>
    <label for="subscribe_uk">
      <input checked="checked" class="checkbox_uk" id="subscribe_regions_" name="subscribe[regions][]" type="checkbox" value="uk" />
      <span class="full_name">United Kingdom</span>
      <span class="short_code">uk</span>
    </label>
</fieldset>


    <input class="button subtle" name="subscribe" type="submit" value="Subscribe" />
  </fieldset>
</form>

      </div>
    </section>
  </div>
</section>

        <footer id="footer">
  <div class="wrapper nocontent">
    <nav>
      <a href="/uk/privacy_policy">Privacy policy</a>
      <a href="/uk/terms_and_conditions">Terms and conditions</a>
      <a href="/uk/corrections">Corrections</a>
      
  <script>
    (function () {
      var d = new Image(1, 1);
      d.onerror = d.onload = function () {
        d.onerror = d.onload = null;
      };
      d.src = ["//secure-au.imrworldwide.com/cgi-bin/m?ci=theconversation&cg=o&cc=1&si=", escape(window.location.href), "&rp=", escape(document.referrer), "&ts=compact&rnd=", (new Date()).getTime()].join('');
    })();
  </script>
  <noscript>
    <div>
      <img src="//secure-au.imrworldwide.com/cgi-bin/m?ci=theconversation&amp;cg=o&amp;cc=1&amp;ts=noscript" width="1" height="1" alt="">
    </div>
  </noscript>

    </nav>
    <p class="copyright">
      <span>Copyright &copy; 2010–2014</span><span class="comma">, </span><span><a href="/uk/who_we_are">The Conversation Trust (UK)</a></span>
    </p>
  </div>
</footer>

      </div>

    <nav id="admin-menu">
  </nav>

  </div>

  <script src="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/assets/vendored-606d289669e9c12fb7932ac818d2841b.js"></script>
<script src="https://62e528761d0685343e1c-f3d1b99a743ffa4142d9d7f1978d9686.ssl.cf2.rackcdn.com/assets/application-3a4efe1b65c9734bfd0d62051f8b1c5c.js"></script>
  <script>
//<![CDATA[


    TC.currentUser = new TC.User(null);
      TC.page = new TC.ContentPage({
    content_id: 22319,
    current_user_full_name: "",
    current_user_profile_notifications_url: ""
  });

    

//]]>
</script>
  
</body>
</html>
